This website uses cookies. For more information please contact us or consult our privacy policy.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Kate Withers
Kate H. Withers
New York +1 212 841 1214 Download V-card

Kate Withers advises clients of all sizes in connection with mergers and acquisitions, joint ventures, venture capital, private equity and licensing transactions involving technology companies and assets across a variety of industries, including software, financial services, media, internet and life sciences. Her practice focuses on corporate and entrepreneurial transactions involving fintech, ecommerce, SaaS software, gaming, analytics, and digital media companies and technology. Ms. Withers also advises clients in connection with corporate governance matters, and early stage fintech companies in connection with financing transactions.

  • Tencent Holdings in connection with its acquisition of a majority stake SuperCell Oy for $8.6 billion. 
  • The National Geographic Society in connection with its entry into a joint venture with 21st Century Fox covering cable television, technology and media assets in a deal with consideration valued at $725 million.
  • Fortune 100 company in connection with its acquisition of a SaaS software company.
  • BBVA in its acquisition of Simple Finance Technology, a mobile banking company.
  • IBM in connection with the numerous acquisitions of privately held software companies.
  • Entrepreneurs and financial technology companies in connection with venture capital transactions, and securities and general corporate matters. 
  • Software, Internet and transportation companies in connection with intellectual property, technology and software licensing matters.
  • Smart-grid technology company in connection with its acquisition by a Fortune 200 company.
  • Bristol-Myers Squibb in connection with its tax-free split-off of its child health and nutrition business in exchange for over $7 billion of its own stock.
  • The Kennedy Trust for Rheumatology Research in the structured sale of a portion of its worldwide royalty interests in Remicade and Simponi. 
  • Major airline in connection with its internal restructuring and merger with another airline.
  • SandRidge Energy Inc. in connection with an initial public offering of an oil and gas royalty trust for gross proceeds in excess of $600 million.
  • MidFirst Bank in its acquisition of Presidential Financial Corporation from Harbert Private Equity and the Belfer family.   
  • Major pharmaceutical company in connection with its equity investment in a development stage biotechnology company.
  • Numerous private fund bidders in connection with their proposed acquisitions of pharmaceutical royalty interests. 
  • Charlesbank Capital Partners in connection with management equity arrangements for numerous fund investments.
  • SandRidge Energy in connection with the sale of its non-core tertiary recovery business to a private equity fund for $130 million.
  • Global ink and packaging company in connection with its proposed acquisition of interests in a joint venture in multiple Latin American countries.
  • Contech Engineered Solutions in its recapitalization, including implementation of new equity ownership and long term financing of both first lien and second lien debt.

Previous Experience

  • Bank of America, Vice President & Consultant, Strategic Risk and Strategic Information & Analysis
  • The World Bank, Consultant
  • The Wharton School of Business, The University of Pennsylvania School of Medicine & Leonard David Institute of Health Economics, Consultant & Sr. Research Coordinator for a cross-disciplinary research team.
  • Brookings Institution, Economic Studies Program, Research assistant to George Akerlof (2001 Nobel Laureate in economics).
  • New York Super Lawyers, Mergers & Acquisitions "Rising Star" (2016)